SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AutoImmune-AIMM
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: organ who wrote (61)3/29/1997 1:16:00 PM
From: Thomas Stewart   of 298
 
I have. This thread is dead, which makes no sense. This is where the action is, six weeks max til we know. I called the company and was told that results should be out by late April (possibly as early as the 21), or early May.

BTW, I asked about whether the downward motion in the stock might relate to a leak of bad news. Predictably, he said no way, that he and everyone else around the company remained optimistic.

As to valuation, I asked what they would charge for their product. Didn't know, but said if the results were equivalent or better than those for interferons (Avonex, Betaseron) they would set a similar price 8k/year. 250k afflicted in US alone, half of whom suffer from the variety that may be amenable to treatment with Myloral. Do the math!

Of course I have protected myself! I can't understand why this thread is so dead.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News